The Patent Finder

Saniona A/S

Also on record
Records under this name other than the patents Saniona A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.

Back to Saniona A/S

PatentTitleStatus Expires Confidence
US 8,410,271Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,633,2188-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,133,184Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,387,184Pharmaceutical compositions for combination therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,696,350Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Formerly held
Term ended
Term ended Jul 4, 2026 · From the USPTO record
Term endedTerm ended Jul 4, 2026From the USPTO record
US 8,697,721Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Formerly held
Lapsed on the fee record
Ended Apr 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 15, 2026From the USPTO record
US 9,931,329Phenyl triazole derivative and its use for modulating the GABAA receptor complex
Lapsed on the fee record
Ended Apr 3, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2026From the USPTO record
US 9,884,848Phenyl triazole derivative and its use for modulating the GABAA receptor complex
Lapsed on the fee record
Ended Feb 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 6, 2026From the USPTO record
US 8,455,549Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
Lapsed on the fee record
Ended Jun 4, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 4, 2025From the USPTO record
US 9,556,132Tetrazole derivatives and their use as potassium channel modulators
Lapsed on the fee record
Ended Jan 31, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2025From the USPTO record
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited